These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28647532)

  • 1. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.
    Kelly AM; Mathema B; Larson EL
    Int J Antimicrob Agents; 2017 Aug; 50(2):127-134. PubMed ID: 28647532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global epidemiology of carbapenemase-producing Enterobacteriaceae.
    van Duin D; Doi Y
    Virulence; 2017 May; 8(4):460-469. PubMed ID: 27593176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
    Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
    J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.
    Banerjee R; Humphries R
    Virulence; 2017 May; 8(4):427-439. PubMed ID: 27168451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal carriage of carbapenem-resistant
    Mohan B; Prasad A; Kaur H; Hallur V; Gautam N; Taneja N
    Indian J Med Microbiol; 2017; 35(4):555-562. PubMed ID: 29405149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.
    Yamamoto N; Asada R; Kawahara R; Hagiya H; Akeda Y; Shanmugakani RK; Yoshida H; Yukawa S; Yamamoto K; Takayama Y; Ohnishi H; Taniguchi T; Matsuoka T; Matsunami K; Nishi I; Kase T; Hamada S; Tomono K
    J Hosp Infect; 2017 Nov; 97(3):212-217. PubMed ID: 28736270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
    Mortensen JE; DeBurger B; Powell EA; DiFranco-Fisher J; Koeth L; Weissman SJ
    J Glob Antimicrob Resist; 2016 Dec; 7():141-144. PubMed ID: 27835839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
    Wong D; Spellberg B
    Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.
    Fang L; Lu X; Xu H; Ma X; Chen Y; Liu Y; Hong G; Liang X
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31281931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
    Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
    Logan LK; Weinstein RA
    J Infect Dis; 2017 Feb; 215(suppl_1):S28-S36. PubMed ID: 28375512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and treatment of community-acquired OXA-48 producing Enterobacteriaceae infections in Tunisia.
    Mnif B; Hammami A
    J Microbiol Immunol Infect; 2020 Apr; 53(2):360-362. PubMed ID: 31704244
    [No Abstract]   [Full Text] [Related]  

  • 14. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?
    Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Rock C; Tamma PD; Cosgrove SE; Maragakis LL; Milstone AM;
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1491-1493. PubMed ID: 30269700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
    Trecarichi EM; Tumbarello M
    Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
    Temkin E; Adler A; Lerner A; Carmeli Y
    Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
    Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
    Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
    Correa AAF; Fortaleza CMCB
    Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Prevalence of carbapenem-resistant Enterobacteriaceae among wounded military personnel.
    Mende K; Beckius ML; Zera WC; Onmus-Leone F; Murray CK; Tribble DR
    US Army Med Dep J; 2017; (2-17):12-17. PubMed ID: 28853114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Molecular detection of extended spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae in a clinical setting.
    Rood IGH; Li Q
    Diagn Microbiol Infect Dis; 2017 Nov; 89(3):245-250. PubMed ID: 28865742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.